GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prism Biolab Co Ltd (TSE:206A) » Definitions » Gross Margin %

Prism Biolab Co (TSE:206A) Gross Margin % : 60.95% (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Prism Biolab Co Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Prism Biolab Co's Gross Profit for the six months ended in Mar. 2024 was 円70.4 Mil. Prism Biolab Co's Revenue for the six months ended in Mar. 2024 was 円115.5 Mil. Therefore, Prism Biolab Co's Gross Margin % for the quarter that ended in Mar. 2024 was 60.95%.


The historical rank and industry rank for Prism Biolab Co's Gross Margin % or its related term are showing as below:

TSE:206A' s Gross Margin % Range Over the Past 10 Years
Min: 60.95   Med: 83.82   Max: 96.53
Current: 60.95


During the past 2 years, the highest Gross Margin % of Prism Biolab Co was 96.53%. The lowest was 60.95%. And the median was 83.82%.

TSE:206A's Gross Margin % is ranked better than
50.4% of 746 companies
in the Biotechnology industry
Industry Median: 60.565 vs TSE:206A: 60.95

Prism Biolab Co had a gross margin of 60.95% for the quarter that ended in Mar. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Prism Biolab Co was 0.00% per year.


Prism Biolab Co Gross Margin % Historical Data

The historical data trend for Prism Biolab Co's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prism Biolab Co Gross Margin % Chart

Prism Biolab Co Annual Data
Trend Sep22 Sep23
Gross Margin %
96.53 71.11

Prism Biolab Co Semi-Annual Data
Sep22 Sep23 Mar24
Gross Margin % - - 60.95

Competitive Comparison of Prism Biolab Co's Gross Margin %

For the Biotechnology subindustry, Prism Biolab Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prism Biolab Co's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Prism Biolab Co's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Prism Biolab Co's Gross Margin % falls into.



Prism Biolab Co Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Prism Biolab Co's Gross Margin for the fiscal year that ended in Sep. 2023 is calculated as

Gross Margin % (A: Sep. 2023 )=Gross Profit (A: Sep. 2023 ) / Revenue (A: Sep. 2023 )
=80.3 / 112.926
=(Revenue - Cost of Goods Sold) / Revenue
=(112.926 - 32.621) / 112.926
=71.11 %

Prism Biolab Co's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=70.4 / 115.482
=(Revenue - Cost of Goods Sold) / Revenue
=(115.482 - 45.091) / 115.482
=60.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Prism Biolab Co  (TSE:206A) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Prism Biolab Co had a gross margin of 60.95% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Prism Biolab Co Gross Margin % Related Terms

Thank you for viewing the detailed overview of Prism Biolab Co's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Prism Biolab Co Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
2-26-1 Muraokahigashi, Kanagawa, Fujisawa, JPN, 251-8555
Prism Biolab Co Ltd is engaged in drug discovery and development based on PepMetics Technology, a proprietary platform technology.

Prism Biolab Co Headlines

No Headlines